Global Afatinib Dimaleate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 111
Published Date: 16 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Afatinib Dimaleate market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Afatinib dimaleate is an oral molecular targeted drug developed and produced by Boehringer Ingelheim, Germany. It is a TKIs with strong and irreversible dual inhibitory effect on EGFR and HER2, and was approved by THE US FDA in July 2013.It is not only suitable for first-line treatment of metastatic NSCLC with EGFR exon 19 deletion mutation or exon 21 (L858R) replacement mutation, but also a second - and third-line target drug for egFR-TKIS resistance.
In recent years, Alfatinib maleate has become a highly anticipated topic in the field of cancer. As a targeted therapeutic drug, it can help control the spread and growth of many cancers, such as non-small cell lung cancer, breast cancer, liver cancer, kidney cancer, stomach cancer, colorectal cancer, etc.
As a second-generation drug, afatinib maleate has good development prospects. For patients, afatinib maleate provides them with more and better treatment options; For pharmaceutical companies, afatinib maleate is a potential best-selling product worth developing.
The Global Info Research report includes an overview of the development of the Afatinib Dimaleate industry chain, the market status of Hospital (20 mg, 30 mg), Clinic (20 mg, 30 mg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Afatinib Dimaleate.
Regionally, the report analyzes the Afatinib Dimaleate markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Afatinib Dimaleate market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Afatinib Dimaleate market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Afatinib Dimaleate industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 20 mg, 30 mg).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Afatinib Dimaleate market.
Regional Analysis: The report involves examining the Afatinib Dimaleate market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Afatinib Dimaleate market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Afatinib Dimaleate:
Company Analysis: Report covers individual Afatinib Dimaleate manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Afatinib Dimaleate This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Afatinib Dimaleate. It assesses the current state, advancements, and potential future developments in Afatinib Dimaleate areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Afatinib Dimaleate market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Afatinib Dimaleate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
20 mg
30 mg
40 mg
Market segment by Application
Hospital
Clinic
Major players covered
Kelun－Kazpharm
Qilu Pharmaceutical
Boehringer-Ingelheim
CSPC Pharmaceutical
Merck
Hansoh Pharmaceuticak
Beacon Pharmaceuticals
Qingfeng Medicine Group
Yangtze River Pharm
Chia Tai-Tianqing
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Afatinib Dimaleate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Afatinib Dimaleate, with price, sales, revenue and global market share of Afatinib Dimaleate from 2019 to 2024.
Chapter 3, the Afatinib Dimaleate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afatinib Dimaleate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Afatinib Dimaleate market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Afatinib Dimaleate.
Chapter 14 and 15, to describe Afatinib Dimaleate sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Afatinib Dimaleate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Afatinib Dimaleate Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 20 mg
1.3.3 30 mg
1.3.4 40 mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Afatinib Dimaleate Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Afatinib Dimaleate Market Size & Forecast
1.5.1 Global Afatinib Dimaleate Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Afatinib Dimaleate Sales Quantity (2019-2030)
1.5.3 Global Afatinib Dimaleate Average Price (2019-2030)
2.1 Kelun－Kazpharm
2.1.1 Kelun－Kazpharm Details
2.1.2 Kelun－Kazpharm Major Business
2.1.3 Kelun－Kazpharm Afatinib Dimaleate Product and Services
2.1.4 Kelun－Kazpharm Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Kelun－Kazpharm Recent Developments/Updates
2.2 Qilu Pharmaceutical
2.2.1 Qilu Pharmaceutical Details
2.2.2 Qilu Pharmaceutical Major Business
2.2.3 Qilu Pharmaceutical Afatinib Dimaleate Product and Services
2.2.4 Qilu Pharmaceutical Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Qilu Pharmaceutical Recent Developments/Updates
2.3 Boehringer-Ingelheim
2.3.1 Boehringer-Ingelheim Details
2.3.2 Boehringer-Ingelheim Major Business
2.3.3 Boehringer-Ingelheim Afatinib Dimaleate Product and Services
2.3.4 Boehringer-Ingelheim Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer-Ingelheim Recent Developments/Updates
2.4 CSPC Pharmaceutical
2.4.1 CSPC Pharmaceutical Details
2.4.2 CSPC Pharmaceutical Major Business
2.4.3 CSPC Pharmaceutical Afatinib Dimaleate Product and Services
2.4.4 CSPC Pharmaceutical Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CSPC Pharmaceutical Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Afatinib Dimaleate Product and Services
2.5.4 Merck Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Hansoh Pharmaceuticak
2.6.1 Hansoh Pharmaceuticak Details
2.6.2 Hansoh Pharmaceuticak Major Business
2.6.3 Hansoh Pharmaceuticak Afatinib Dimaleate Product and Services
2.6.4 Hansoh Pharmaceuticak Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hansoh Pharmaceuticak Recent Developments/Updates
2.7 Beacon Pharmaceuticals
2.7.1 Beacon Pharmaceuticals Details
2.7.2 Beacon Pharmaceuticals Major Business
2.7.3 Beacon Pharmaceuticals Afatinib Dimaleate Product and Services
2.7.4 Beacon Pharmaceuticals Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Beacon Pharmaceuticals Recent Developments/Updates
2.8 Qingfeng Medicine Group
2.8.1 Qingfeng Medicine Group Details
2.8.2 Qingfeng Medicine Group Major Business
2.8.3 Qingfeng Medicine Group Afatinib Dimaleate Product and Services
2.8.4 Qingfeng Medicine Group Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Qingfeng Medicine Group Recent Developments/Updates
2.9 Yangtze River Pharm
2.9.1 Yangtze River Pharm Details
2.9.2 Yangtze River Pharm Major Business
2.9.3 Yangtze River Pharm Afatinib Dimaleate Product and Services
2.9.4 Yangtze River Pharm Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Yangtze River Pharm Recent Developments/Updates
2.10 Chia Tai-Tianqing
2.10.1 Chia Tai-Tianqing Details
2.10.2 Chia Tai-Tianqing Major Business
2.10.3 Chia Tai-Tianqing Afatinib Dimaleate Product and Services
2.10.4 Chia Tai-Tianqing Afatinib Dimaleate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Chia Tai-Tianqing Recent Developments/Updates
3.1 Global Afatinib Dimaleate Sales Quantity by Manufacturer (2019-2024)
3.2 Global Afatinib Dimaleate Revenue by Manufacturer (2019-2024)
3.3 Global Afatinib Dimaleate Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Afatinib Dimaleate by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Afatinib Dimaleate Manufacturer Market Share in 2023
3.4.2 Top 6 Afatinib Dimaleate Manufacturer Market Share in 2023
3.5 Afatinib Dimaleate Market: Overall Company Footprint Analysis
3.5.1 Afatinib Dimaleate Market: Region Footprint
3.5.2 Afatinib Dimaleate Market: Company Product Type Footprint
3.5.3 Afatinib Dimaleate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Afatinib Dimaleate Market Size by Region
4.1.1 Global Afatinib Dimaleate Sales Quantity by Region (2019-2030)
4.1.2 Global Afatinib Dimaleate Consumption Value by Region (2019-2030)
4.1.3 Global Afatinib Dimaleate Average Price by Region (2019-2030)
4.2 North America Afatinib Dimaleate Consumption Value (2019-2030)
4.3 Europe Afatinib Dimaleate Consumption Value (2019-2030)
4.4 Asia-Pacific Afatinib Dimaleate Consumption Value (2019-2030)
4.5 South America Afatinib Dimaleate Consumption Value (2019-2030)
4.6 Middle East and Africa Afatinib Dimaleate Consumption Value (2019-2030)
5.1 Global Afatinib Dimaleate Sales Quantity by Type (2019-2030)
5.2 Global Afatinib Dimaleate Consumption Value by Type (2019-2030)
5.3 Global Afatinib Dimaleate Average Price by Type (2019-2030)
6.1 Global Afatinib Dimaleate Sales Quantity by Application (2019-2030)
6.2 Global Afatinib Dimaleate Consumption Value by Application (2019-2030)
6.3 Global Afatinib Dimaleate Average Price by Application (2019-2030)
7.1 North America Afatinib Dimaleate Sales Quantity by Type (2019-2030)
7.2 North America Afatinib Dimaleate Sales Quantity by Application (2019-2030)
7.3 North America Afatinib Dimaleate Market Size by Country
7.3.1 North America Afatinib Dimaleate Sales Quantity by Country (2019-2030)
7.3.2 North America Afatinib Dimaleate Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Afatinib Dimaleate Sales Quantity by Type (2019-2030)
8.2 Europe Afatinib Dimaleate Sales Quantity by Application (2019-2030)
8.3 Europe Afatinib Dimaleate Market Size by Country
8.3.1 Europe Afatinib Dimaleate Sales Quantity by Country (2019-2030)
8.3.2 Europe Afatinib Dimaleate Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Afatinib Dimaleate Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Afatinib Dimaleate Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Afatinib Dimaleate Market Size by Region
9.3.1 Asia-Pacific Afatinib Dimaleate Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Afatinib Dimaleate Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Afatinib Dimaleate Sales Quantity by Type (2019-2030)
10.2 South America Afatinib Dimaleate Sales Quantity by Application (2019-2030)
10.3 South America Afatinib Dimaleate Market Size by Country
10.3.1 South America Afatinib Dimaleate Sales Quantity by Country (2019-2030)
10.3.2 South America Afatinib Dimaleate Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Afatinib Dimaleate Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Afatinib Dimaleate Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Afatinib Dimaleate Market Size by Country
11.3.1 Middle East & Africa Afatinib Dimaleate Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Afatinib Dimaleate Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Afatinib Dimaleate Market Drivers
12.2 Afatinib Dimaleate Market Restraints
12.3 Afatinib Dimaleate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Afatinib Dimaleate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Afatinib Dimaleate
13.3 Afatinib Dimaleate Production Process
13.4 Afatinib Dimaleate Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Afatinib Dimaleate Typical Distributors
14.3 Afatinib Dimaleate Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Afatinib Dimaleate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Afatinib Dimaleate Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Kelun－Kazpharm Basic Information, Manufacturing Base and Competitors
Table 4. Kelun－Kazpharm Major Business
Table 5. Kelun－Kazpharm Afatinib Dimaleate Product and Services
Table 6. Kelun－Kazpharm Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Kelun－Kazpharm Recent Developments/Updates
Table 8. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Qilu Pharmaceutical Major Business
Table 10. Qilu Pharmaceutical Afatinib Dimaleate Product and Services
Table 11. Qilu Pharmaceutical Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Qilu Pharmaceutical Recent Developments/Updates
Table 13. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer-Ingelheim Major Business
Table 15. Boehringer-Ingelheim Afatinib Dimaleate Product and Services
Table 16. Boehringer-Ingelheim Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Boehringer-Ingelheim Recent Developments/Updates
Table 18. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. CSPC Pharmaceutical Major Business
Table 20. CSPC Pharmaceutical Afatinib Dimaleate Product and Services
Table 21. CSPC Pharmaceutical Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CSPC Pharmaceutical Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Afatinib Dimaleate Product and Services
Table 26. Merck Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Hansoh Pharmaceuticak Basic Information, Manufacturing Base and Competitors
Table 29. Hansoh Pharmaceuticak Major Business
Table 30. Hansoh Pharmaceuticak Afatinib Dimaleate Product and Services
Table 31. Hansoh Pharmaceuticak Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Hansoh Pharmaceuticak Recent Developments/Updates
Table 33. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Beacon Pharmaceuticals Major Business
Table 35. Beacon Pharmaceuticals Afatinib Dimaleate Product and Services
Table 36. Beacon Pharmaceuticals Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Beacon Pharmaceuticals Recent Developments/Updates
Table 38. Qingfeng Medicine Group Basic Information, Manufacturing Base and Competitors
Table 39. Qingfeng Medicine Group Major Business
Table 40. Qingfeng Medicine Group Afatinib Dimaleate Product and Services
Table 41. Qingfeng Medicine Group Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Qingfeng Medicine Group Recent Developments/Updates
Table 43. Yangtze River Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Yangtze River Pharm Major Business
Table 45. Yangtze River Pharm Afatinib Dimaleate Product and Services
Table 46. Yangtze River Pharm Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Yangtze River Pharm Recent Developments/Updates
Table 48. Chia Tai-Tianqing Basic Information, Manufacturing Base and Competitors
Table 49. Chia Tai-Tianqing Major Business
Table 50. Chia Tai-Tianqing Afatinib Dimaleate Product and Services
Table 51. Chia Tai-Tianqing Afatinib Dimaleate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Chia Tai-Tianqing Recent Developments/Updates
Table 53. Global Afatinib Dimaleate Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Afatinib Dimaleate Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Afatinib Dimaleate Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Afatinib Dimaleate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Afatinib Dimaleate Production Site of Key Manufacturer
Table 58. Afatinib Dimaleate Market: Company Product Type Footprint
Table 59. Afatinib Dimaleate Market: Company Product Application Footprint
Table 60. Afatinib Dimaleate New Market Entrants and Barriers to Market Entry
Table 61. Afatinib Dimaleate Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Afatinib Dimaleate Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Afatinib Dimaleate Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Afatinib Dimaleate Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Afatinib Dimaleate Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Afatinib Dimaleate Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Afatinib Dimaleate Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Afatinib Dimaleate Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Afatinib Dimaleate Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Afatinib Dimaleate Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Afatinib Dimaleate Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Afatinib Dimaleate Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Afatinib Dimaleate Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Afatinib Dimaleate Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Afatinib Dimaleate Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Afatinib Dimaleate Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Afatinib Dimaleate Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Afatinib Dimaleate Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Afatinib Dimaleate Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Afatinib Dimaleate Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Afatinib Dimaleate Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Afatinib Dimaleate Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Afatinib Dimaleate Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Afatinib Dimaleate Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Afatinib Dimaleate Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Afatinib Dimaleate Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Afatinib Dimaleate Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Afatinib Dimaleate Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Afatinib Dimaleate Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Afatinib Dimaleate Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Afatinib Dimaleate Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Afatinib Dimaleate Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Afatinib Dimaleate Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Afatinib Dimaleate Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Afatinib Dimaleate Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Afatinib Dimaleate Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Afatinib Dimaleate Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Afatinib Dimaleate Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Afatinib Dimaleate Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Afatinib Dimaleate Raw Material
Table 121. Key Manufacturers of Afatinib Dimaleate Raw Materials
Table 122. Afatinib Dimaleate Typical Distributors
Table 123. Afatinib Dimaleate Typical Customers
List of Figures
Figure 1. Afatinib Dimaleate Picture
Figure 2. Global Afatinib Dimaleate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Afatinib Dimaleate Consumption Value Market Share by Type in 2023
Figure 4. 20 mg Examples
Figure 5. 30 mg Examples
Figure 6. 40 mg Examples
Figure 7. Global Afatinib Dimaleate Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Afatinib Dimaleate Consumption Value Market Share by Application in 2023
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global Afatinib Dimaleate Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Afatinib Dimaleate Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Afatinib Dimaleate Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Afatinib Dimaleate Average Price (2019-2030) & (US$/Unit)
Figure 15. Global Afatinib Dimaleate Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Afatinib Dimaleate Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Afatinib Dimaleate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Afatinib Dimaleate Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Afatinib Dimaleate Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Afatinib Dimaleate Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Afatinib Dimaleate Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Afatinib Dimaleate Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Afatinib Dimaleate Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Afatinib Dimaleate Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Afatinib Dimaleate Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Afatinib Dimaleate Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Afatinib Dimaleate Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Afatinib Dimaleate Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Afatinib Dimaleate Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Afatinib Dimaleate Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Afatinib Dimaleate Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Afatinib Dimaleate Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Afatinib Dimaleate Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Afatinib Dimaleate Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Afatinib Dimaleate Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Afatinib Dimaleate Consumption Value Market Share by Region (2019-2030)
Figure 53. China Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Afatinib Dimaleate Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Afatinib Dimaleate Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Afatinib Dimaleate Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Afatinib Dimaleate Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Afatinib Dimaleate Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Afatinib Dimaleate Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Afatinib Dimaleate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Afatinib Dimaleate Market Drivers
Figure 74. Afatinib Dimaleate Market Restraints
Figure 75. Afatinib Dimaleate Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Afatinib Dimaleate in 2023
Figure 78. Manufacturing Process Analysis of Afatinib Dimaleate
Figure 79. Afatinib Dimaleate Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Kelun－Kazpharm Qilu Pharmaceutical Boehringer-Ingelheim CSPC Pharmaceutical Merck Hansoh Pharmaceuticak Beacon Pharmaceuticals Qingfeng Medicine Group Yangtze River Pharm Chia Tai-Tianqing
Related Reports
11 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
